findmyKOL

John Danias, MD, PhD

Basic profile

SUNY Downstate Health Sciences University

ORCIDNone on fileNPI↗
✓ Full record
RegionBrooklyn, NY · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH funding1999–2026Why? →

John Danias is an Ophthalmology physician affiliated with SUNY Downstate Health Sciences University. OpenAlex indexes 151 publications with 4,180 citations (h-index 34).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
151publications

Distinct works indexed by OpenAlex.

4,180citations

Total citations across indexed works.

34h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
10NIH grants · 1999–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

450 Clarkson Ave
Box 78
Brooklyn, NY 112032012

Telephone

718-780-2600

Registry record last updated 3 Aug 2011.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    90.4%
    Prostaglandin Analog29%
    Latanoprost87%Lumigan9%Travoprost4%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor28.1%
    Dorzolamide-Timolol67%Dorzolamide Hcl16%Brinzolamide9%Azopt4%Simbrinza2%Acetazolamide2%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    5.4%
    Beta blocker5.4%
    Timolol Maleate100%
    Part D≥28 patients
  • Anti-infectives

    1.8%
    Fluoroquinolone Antibacterial1.8%
    Moxifloxacin100%
    Part D≥13 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

10 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”